Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 4 of the 15 sources its claims cite were checked for support.
Abstract
The nuclear-encoded Krebs cycle enzymes, fumarate hydratase (FH) and succinate dehydrogenase (SDHB, -C and -D), act as tumour suppressors. Germline mutations in FH predispose individuals to leiomyomas and renal cell cancer (HLRCC), whereas mutations in SDH cause paragangliomas and phaeochromocytomas (HPGL). In this study, we have shown that FH-deficient cells and tumours accumulate fumarate and, to a lesser extent, succinate. SDH-deficient tumours principally accumulate succinate. In situ analyses showed that these tumours also have over-expression of hypoxia-inducible factor 1alpha (HIF1alpha), activation of HIF1alphatargets (such as vascular endothelial growth factor) and high microvessel density. We found no evidence of increased reactive oxygen species in our cells. Our data provide in vivo evidence to support the hypothesis that increased succinate and/or fumarate causes stabilization of HIF1alpha a plausible mechanism, inhibition of HIF prolyl hydroxylases, has previously been suggested by in vitro studies. The basic mechanism of tumorigenesis in HPGL and HLRCC is likely to be pseudo-hypoxic drive, just as it is in von Hippel-Lindau syndrome.
Overview
CoChat Summary
TL;DR
This study provides in vivo evidence that germline FH and SDH mutations lead to accumulation of Krebs cycle intermediates and HIF1α over-expression in HLRCC and HPGL tumours, supporting pseudo-hypoxic drive as a shared tumorigenic mechanism. It also finds no evidence of increased reactive oxygen species in FH-deficient cells.
Key findings
- FH-deficient fibroblasts and HLRCC fibroids accumulate fumarate and succinate. FH-deficient fibroblast succinate was mean 59.4 mmol/g protein (median 39.8, range 32–125.9) versus controls mean 17.4 (median 14.5, range 9.9–29.8); HLRCC fibroids had succinate 70–98 and fumarate 417–688 mmol/g protein, with succinate:fumarate ratios of 0.10–0.22 versus >1 in myometria.
- SDH-deficient HPGL tumours principally accumulate succinate. SDHB-mutant paragangliomas had succinate 364.5 and 517.0 mmol/g protein versus non-HPGL tumours 32.3–49.7; one SDHB tumour (patient 4) did not show elevated succinate.
- HIF1α over-expression and HIF-target activation were seen in tumours: strong nuclear HIF1α in all HPGL tumours studied (12 paragangliomas and 4 phaeochromocytomas), moderate staining in HLRCC fibroids, and very strong staining in three renal cancers; VEGF expression was high and CD34 showed high microvessel density. Western blotting confirmed a 120 kDa HIF1α band only in tumour, not normal kidney.
- No notable increase in oxidative stress was found: SOD mean was 44.4 versus 38.2 mU/mg and reduced glutathione mean was 5.52 versus 4.04 nmol/mg in FH-deficient versus control cells, with retained mitochondrial complex I, II–III and IV activities.
Methods
- Metabolomic profiling used 1H MRS on skin fibroblasts from four fumarase deficiency patients and six controls, and GC/MS on frozen HLRCC fibroids, myometrium controls, and frozen paragangliomas plus non-HPGL controls.
- Mutation screening of SDHB, SDHC and SDHD was performed by direct sequencing, with array CGH for allelic loss; tumour analyses included HIF1α and CD34 immunohistochemistry, VEGF in situ hybridization, and HIF1α western blotting.
- Samples included HLRCC fibroids and renal cancers, HPGL paragangliomas and phaeochromocytomas, and normal myometrium/kidney controls, all collected with Research Ethics Committee approval.
Limitations
- The paper states that formal statistical analysis was problematic given the small number of samples and lack of information on underlying factors; tumour scarcity also meant duplicate metabolite analysis was not possible.
- The paper notes that one SDHB tumour failed to show elevated succinate for unclear reasons, that HPGL versus other tumour succinate differences were only just significant (P = 0.045) owing to sample 3, and that direct PHD inhibition by fumarate in HLRCC cannot be excluded.
- Evident from the text: HIF1α staining was also weak/moderate in surrounding myometrium, and the oxidative-stress conclusion rests on only two FH-deficient lines for SOD/glutathione assays.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
4 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
§ Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations > INTRODUCTION
What the sources say
- Not checked yetcites [2] Baysal, B.E., Ferrell, R.E., Willett-Brozick, J.E., Lawrence, E.C., Myssiorek, D., Bosch, A., van der Mey, A., Taschner, P.E., Rubinstein, W.S., Myers, E.N. et al. (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science, 287, 848-851. source
- Not checked yetcites [3] Gimm, O., Armanios, M., Dziema, H., Neumann, H.P. and Eng, C. (2000) Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res., 60, 6822-6825.
- Not checked yetcites [4] Niemann, S. and Muller, U. (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet., 26, 268-270. source
- Partly supportedcites [5] Astuti, D., Latif, F., Dallol, A., Dahia, P.L., Douglas, F., George, E., Skoldberg, F., Husebye, E.S., Eng, C. and Maher, E.R. (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet., 69, 49-54. sourceExperimental — accuracy not yet measured
The Abstract and Results of Astuti et al. (2001) support the SDHB component strongly: inactivating germline SDHB mutations were found in eight families 'segregating pheochromocytoma with or without head and neck paraganglioma' plus one occult germline case, and the SDHD association is stated as background ('pheochromocytoma susceptibility has been associated with germline SDHD mutations'). The SDHC component is not this paper's finding: the Results state 'No pathogenic mutations were identified in SDHC' and 'there was no evidence of germline SDHC mutations in the kindreds with familial pheochromocytoma and paraganglioma', with the SDHC link credited to Niemann and Muller (2000) in the Discussion, and the Abstract hedges that SDHC and SDHD mutations 'may cause hereditary paraganglioma'. So the composite claim (B, C and D, stated as established predisposition) overstates what this source reports for SDHC. (LLM, conf=0.78)
- Not checked yetcites [6] Astuti, D., Douglas, F., Lennard, T.W., Aligianis, I.A., Woodward, E.R., Evans, D.G., Eng, C., Latif, F. and Maher, E.R. (2001) Germline SDHD mutation in familial phaeochromocytoma. Lancet, 357, 1181-1182. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“neither our data nor those of Selak et al. (27) have provided evidence for an alternative model of tumorigenesis in HLRCC or HPGL based on increased levels of ROSs.”
§ Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations > DISCUSSION
What the sources say
- Partly supportedcites [27] Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B. and Gottlieb, E. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell, 7, 77-85. sourceExperimental — accuracy not yet measured
In “Reactive oxygen species do not play a role in HIF-1α induction after SDH inhibition” (page not available), Selak et al. report no detectable increase in ROS or change in glutathione redox state after SDH inhibition. That supports the statement as applied to the SDH-related HPGL model, but these data do not test the FH-related HLRCC model. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Selak et al. (27) showed that the mechanism for these findings may be inhibition by succinate of HIF PHDs, which rely for their activity on conversion of a-ketoglutarate to succinate.”
§ Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations > DISCUSSION
What the sources say
- Supportedcites [27] Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B. and Gottlieb, E. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell, 7, 77-85. source
The Introduction states that HIF prolyl hydroxylases use α-ketoglutarate and convert it to succinate during hydroxylation. In “Succinate is accumulated in SDH-inhibited cells,” the authors propose that accumulated succinate may inhibit this required reaction and impede PHD activity. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Selak et al. (27) tested a model of tumorigenesis in which raised levels of succinate caused increased HIF1a expression in vitro.”
§ Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations > DISCUSSION
What the sources say
- Supportedcites [27] Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B. and Gottlieb, E. (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell, 7, 77-85. source
In the section on succinate elevation and HIF-1α stabilization in cells (page unavailable), Selak et al. report that cells treated with a membrane-permeable succinate derivative had elevated HIF-1α levels under normoxic conditions. This supports the attributed in-vitro model; the measured increase was in HIF-1α protein levels, through stabilization. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“FH-deficient cells and tumours accumulate fumarate and, to a lesser extent, succinate.”
§ Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
40 more claims
Create a free account to see all 78 claims and to verify the 11 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 14
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elevation of fumarate and succinate, such as in renal cancer subtypes bearing succinate dehydrogenase (SDH) or fumarate hydratase mutations, suppress HIF-α hydroxylation by the PHDs, resulting in the stabilization of both HIF-1α and HIF-2α [20].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intriguingly, unlike pVHL-deficient ccRCC tumors that constitutively express both HIF isoforms or HIF-2α preferentially, renal cancers bearing FH/SDH mutations tend to preferentially express HIF-1α [20].”
From The HIF Axes in Cancer - Angiogenesis, Metabolism and Immune-Modulation (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, succinate and fumarate inhibit the prolyl hydroxylase domain-containing (PHD) enzymes that regulate stability of hypoxia-inducible factors (HIFs), such that FH and SDH deficient cancers activate the hypoxic gene expression program even under normoxic conditions (Hewitson et al., 2007; Pollard et al., 2005; Selak et al., 2005).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Pollard et al., 2005
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“To date, the clearest evidence that metabolites modulate HIF signaling comes from cells that are genetically defective in fumarate hydratase (FH) (Isaacs et al., 2005) or succinate hydrogenase (SDH; subunits b, c, and d) (MacKenzie et al., 2007; Pollard et al., 2005; Selak et al., 2005).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Pollard et al., 2005
In the citing paper
“For example, the increase in ROS induced by antimycin A can be abolished by adding either stigmatellin or myxothiazol (256).”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [256]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations > Increased succinate in HPGL tumours
“One SDHB tumour (patient 4) did not show elevated succinate.”
§ Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations > Western blotting
“| 4 | No | 32.3 | 3.0 | 10.8 |”
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 1×
“Mutations in VHL cause stabilization of the subunits of hypoxia-inducible factor (HIF) (18), which initiates the transcription of genes coding for pro-angiogenic proteins such as VEGF (19).”
BackgroundSuccinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 4×
“Recently, support has been provided using an in vitro system for dysfunction of the Krebs cycle leading to the stabilization of HIF (27).”
BackgroundInfluentialMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Self-citationTransition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · cited 1×
“Oxidative stress in FH-deficient and control cells was measured using a HPLC method to analyse the oxidation status of the antioxidant glutathione as previously described (33).”
Method[45] Cytochrome oxidase from beef heart mitochondria
Wharton, D. C., & Tzagoloff, A. (1967) · Methods in Enzymology · doi:10.1016/0076-6879(67)10048-7 · Cited by 1,261
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Architecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927
Neumann, H. P. H. (2004) · JAMA · doi:10.1001/jama.292.8.943 · Cited by 893 · cited 1×
“SDHB mutations are associated with a higher proportion of malignant lesions and a relatively greater risk of phaeochromocytoma (8).”
Background
Cited by
Items 801–900 of 982
Integral action of hypoxia-inducible HIF prolyl-4-hydroxylases in mammalian oxygen sensing
Stiehl, D. P. (2012) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-71218 · Cited by 1
Impériale, A. (2014) · theses.fr (ABES) · doi:10.70675/f8e51b70zbc26z42f5z91fcz3e1b3a3e8c91 · Cited by 1
Exploitation du métabolisme mitochondrial oxydatif dans l'éradication du mélanome métastatique
Corazao-Rozas, P. (2014) · theses.fr (ABES) · doi:10.70675/3d88f99ez2701z47dbz8852za1e300c8109e · Cited by 1
Regulation of Glucose and Energy Metabolism in Cancer Cells by Hypoxia Inducible Factor 1
Ferreira, T. C., & Campos, E. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_6 · Cited by 1
Régulation du métabolisme énergétique : étude du remodelage bioénergétique du cancer
Obre, É. (2014) · theses.fr (ABES) · doi:10.70675/a13a8983z3058z4251z88cdz259d721b0a3f
“L'accumulation de succinate dans le cytosol permet l'inhibition de la dégradation de HIF et favorise sa stabilisation (Pollard et al., 2005).”
BackgroundPeutz-Jeghers Polyposis and the LKB1 Tumor Suppressor
Udd, L. (2012) · Helda - University of Helsinki Institutional Repository
Loureiro, V. C. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2007.tde-22042007-204736
Recent Progress in Clinical Magnetic Resonance Spectroscopy
Lin, A., & Ross, B. D. (1996) · Wiley eBooks · doi:10.1002/9780470034590.emrstm1055
From chromaffin cells to Phaeochromocytoma: insight into the sympathoadrenal cell lineage
Cleary, S. (2007) · Murdoch University Research Portal
Smith, G. (2015) · Enlighten: Theses (The University of Glasgow)
Signal integration between notch and hypoxia : insights into development and disease
Gustafsson, M. V. (2007) · Figshare
Mutations de gènes impliqués dans le métabolisme énergétique et cancer
Thibault, C., & Gimenez‐Roqueplo, A. (2013) · ONCOLOGIE · doi:10.1007/s10269-013-2320-8
“L’analyse supervisée du transcriptome de PH/PGL génétiquement déterminés avec 54 gènes régulés par HIF-α a permis de classer les tumeurs en deux clusters : le premier regroupant les tumeurs avec mutations des gènes SDHs ou VHL et le second regroupant les tumeurs porteuses de mutations NF1 ou RET [14].”
BackgroundInfluentialMitochondrial Complex II in Cancer
Kľučková, K., Neužil, J., & Rohlena, J. (2014) · Springer eBooks · doi:10.1007/978-94-017-8984-4_4
Kunkle, B. W. (2011) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi11120809
Panizza, E. (2011) · DSpaceUnipr (University of Parma) · Cited by 1
The regulation of hypoxia-inducible factor (HIF-1) and the role of HIF-1 in C. elegans longevity
Zhai, Z. (2010) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-2485
“…groups reported that the accumulation of mitochondria TCA cycle intermediates caused by genetic mutations of some key enzymes promoted HIF-1 stabilization in tumor cell line, and this is thought to contribute to the highly vascularization in solid tumor (Pollard et al., 2005; Selak et al., 2005).”
BackgroundOttaviani, L. (2015) · DSpaceUnipr (University of Parma)
Webb, J. D. (2008) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-7rkq2rapj
Arigony, A. L. V. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Mujer con paragangliomatosis múltiple: una revisión del aspecto genético
Boente, R., Fojón, M. S., Rouco, J. S. R., Trinidad, C., Carrero, J. L., de Vega, M. P., & Miguel, P. D. S. (2008) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(08)70662-4
Genetic Counseling in Renal Masses
López‐Guerrero, J. A., García‐Casado, Z., Fernández‐Serra, A., & Rubio‐Briones, J. (2008) · Advances in Urology · doi:10.1155/2008/720840
“Recent studies suggest that HIF overexpression is involved in HLRCC tumorigenesis [42, 63].”
BackgroundBiomarkers for Prognosis and Molecularly Targeted Therapy in Renal Cell Carcinoma
Schmidt, L. S. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_11
O′Flaherty, L., & O'Flaherty, L. (2012) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-e240ae7pp
Characterising the tumour suppression function of folliculin
Preston, R. S. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Familial and inherited renal cancers
Barrett, T., & Choyke, P. L. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545436.005
METABOLOMICS AND PROTEOMICS STUDIES OF BRAIN TUMORS - A CHEMOMETRIC BIOINFORMATICS APPROACH
Mörén, L. (2015) · DiVA (Digitala Vetenskapliga Arkivet)
Phénotype métabolique des tumeurs associées à des anomalies du cycle de Krebs
Janin, M. (2015) · theses.fr (ABES) · doi:10.70675/c12cbd69zd09fz4fddz91dbz86f7655d32c8
“In patients suffering from acute myeloid leukemias (AML), 2-HG level in serum is a predictor of the presence of IDH mutations and patient outcome.2–4 Although the precise oncogenic consequences of IDH mutations remain unclear, high levels of 2-HG have been shown to inhibit aKG-dependent dioxygenases, including the Egl…”
BackgroundInfluentialReviewArticle Genetic Counseling in Renal Masses
Antônio, L. (2008)
Lussey‐Lepoutre, C. (2015) · theses.fr (ABES) · doi:10.70675/024d7dfdz0a77z4938z961aza39e67b5ea2a
Carcinomes à cellules rénales: de la pathologie aux voies moléculaires de la carcinogenèse
Perrin, C., Edeline, J., Vigneau, C. M., Patard, J., & Rioux-Leclercq, N. C. (2009) · ONCOLOGIE · doi:10.1007/s10269-009-1064-y
Hsu, P. P. (2011) · DSpace@MIT (Massachusetts Institute of Technology)
Coordinated regulation of glycolysis and the folate one-carbon cycle
Fiske, B. P. (2015) · DSpace@MIT (Massachusetts Institute of Technology)
The effects of hyperglycemia on glucose metabolism in epithelial ovarian cancer
Kellenberger, L. D. (2016) · The Atrium (University of Guelph)
A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody
Bader, A. G., Brown, D., Winkler, M., Shim, E., Livi, C. B., Rakheja, D., Tan, J. C., Benson, D. G., Parekh, V., Kho, E.-Y., et al. (2014)
Do, H.-W. (2015) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-avrorgeev
Alteration in Transcriptional State, as a First Step in Cancer Development
S, L. S. T. (2014) · Pharmaceutica Analytica Acta · doi:10.4172/2153-2435.1000e166
“Importantly, TCA-cycle enzymes, FH (Fumarate hydratase) and SDH (Succinate Dehydrogenase) have been suggested as tumor suppressors [5].”
BackgroundThe role of mediator complex subunit 12 (MED12) in the murine reproductive tract
Mittal, P. (2015) · D-Scholarship@Pitt (University of Pittsburgh) · doi:10.13140/rg.2.2.20308.60809
Cazzaniga, M. (2016) · BOA (University of Milano-Bicocca)
Life without Phd? – Phd Oxygen Sensor Proteins in Hypoxic Carcinoma Cell Survival
Högel, H. (2016) · UTUPub (University of Turku)
Unraveling cancer metabolism through flux analysis and metabolic engineering
Tavares, L. C. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Exome sequencing and human disease : the molecular characterisation of genetic disorders
Walsh, D. M. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
The pathophysiology of dysfunctionaluterine bleeding
Nowak, R. A. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203091500.048
Su, D., Metwalli, A. R., & Srinivasan, R. (2016) · Springer eBooks · doi:10.1007/978-3-319-30046-7_1
Molecular regulations and lineage tracing in early mouse embryogenesis
Zhou, W. (2012) · ResearchWorks at the University of Washington (University of Washington)
Molecular mecanisms involved in the pathogenesis of head and neck paragangliomas
Merlo, A. (2014) · Repositorio de la Universidad de Oviedo (RUO)
The Role of Mediator Complex Subunit 12 in Leiomyoma Biology
Mittal, P., Wang, X., & Rajkovic, A. (2016) · Current Genetic Medicine Reports · doi:10.1007/s40142-016-0106-1
“Bialleleic inactivation of FH mostly occurs due to loss of heterozygosity events triggered by environmental factors [52, 57], which may render fumarase inactive, causing a buildup of fumarate or succinate in the cell [58].”
BackgroundMolecular characterisation of renal cell carcinoma and related disorders
Jafri, M. (2016) · University of Birmingham Institutional Research Archive (University of Birmingham)
Investigation of Succinated Protein Turnover by Autophagy
Proctor, L. J. (2016) · Scholar Commons (University of South Carolina)
Unraveling the (epi)genetic makeup of myeloid malignancies
Kroeze, L. I. (2016) · Radboud Repository (Radboud University)
Molecular Genetics of Pheochromocytoma and Paraganglioma
Robledo, M., Currás-Freixes, M., & Cascón, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_2
Metabolic rewiring in response to genetic and environmental preturbations in cancer
Hollinshead, K. E. R. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham)
The Emerging Genetic Landscape in Renal Cell Carcinoma
Willoughby, K., & Drabkin, H. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800886-7.00029-7
Opportunity for Disease-Specific Approaches to Therapy
Pfaffenroth, E. C., & Linehan, W. M. (2009)
Regulation of Cellular Oxygen Sensing Pathways by VHL
Heir, P. (2015) · TSpace (University of Toronto)
Effect of short-term Cr(VI) exposure on energy metabolisn in human lung epithelial cells
Cerveira, J. F. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
MIRNA-BASED METABOLIC MODULATION IN GLIOBLASTOMA CELLS: A STRATEGY TO SURPASS TUMOR CHEMORESISTANCE
Sousa, M. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Rao, J. U. (2017) · Radboud Repository (Radboud University)
Inhibition of Tumor Angiogenesis in GIST Therapy
Benson, C., & Libertini, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_19
Genes Encoding Succinate Dehydrogenase as Susceptibility Factors in Cowden and Cowden-Like Syndrome
Ni, Y. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
Untersuchung neuer Regulatoren der Glukose-stimulierten Genexpression
Knauer, M. (2017) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-18108
Genetic alterations in MENX-associated pheochromocytoma
Shyla, A. (2008) · mediaTUM (Technical University of Munich)
Alonso, A. H. (2016) · Library Open Repository (Universidad Complutense Madrid)
Atay, Ç. (2013) · mediaTUM (Technical University of Munich)
Freixes, M. C. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Pheochromocytomas and Paragangliomas: Genetics and Pathophysiology
Fishbein, L. M. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_8
Succination Impairs Protein Folding and Promotes Chop Stability in the Adipocyte during Diabetes
Manuel, A. M. (2017) · Scholar Commons (University of South Carolina)
Greim, H. A., Hartwig, A., & MAK Commission (2016) · Wiley eBooks · doi:10.1002/3527600418.mbphaeoe4916
Philip, B. (2014) · Griffith Research Online · doi:10.25904/1912/1367
Genetic Profiling of Phaeochromocytoma and Paraganglioma Using Next Generation Sequencer
Pillai, S. (2017) · Griffith Research Online · doi:10.25904/1912/1252
Hereditary paraganglioma : genetics and tumor biology
Hoekstra, A. S. (2017) · Leiden Repository (Leiden University)
Tamura, T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/281253
“The accumulated succinate and fumarate act as competitive inhibitors of α -KG-dependent oxygenases that regulate the hypoxia-inducible factor (HIF) oncogenic pathway [5,10,15,17].”
BackgroundWeaver, J. R., CASELLINI, C. M., Parson, H. K., & Vinik, A. I. (2018) · AACE Clinical Case Reports · doi:10.4158/accr-2017-0109
The role of respiration in supporting cell proliferation
Gui, D. Y. (2017) · DSpace@MIT (Massachusetts Institute of Technology)
The Metabolic Needs of Epithelial to Mesenchymal Transition
Nunes, J. C. B. G. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/1wf0-8p61
Investigating the role of factor inhibiting HIF (FIH) in tumourigenesis
Ma, J. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-00yoqqjwv
Yambire, K. F. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7142
Kamai, T., Abe, H., Murakami, S., Kuroda, H., Jamiyan, T., Arai, K., & Yoshida, K. (2019)
Fonseca, J. (2019) · Brock University Digital Repository (Brock University)
Identification of new phaeochromocytoma and paraganglioma susceptibility genes
Medina, L. R. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Identification de nouveaux gènes de prédisposition aux parangangliomes
Buffet, A. (2018) · theses.fr (ABES) · doi:10.70675/919a7ecez1b81z4189z937fz709f94a68c6d
Signaling Pathways Involved in Kidney and Urinary Tract Physiology and Pathology
Lobo, J., & Henrique, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-44436-5_6
Rôle de la cytidine désaminase dans le contrôle du métabolisme énergétique tumoral pancréatique
Francès, A. (2019) · theses.fr (ABES) · doi:10.70675/0ff20700z0c7az46baz8554z84e4b0d0d4ff
Analysis of molecular links between epigenetic regulations and energy metabolism
Miezaniec, A. (2020) · Nottingham ePrints (University of Nottingham)
Venkatasubramanian, H., Selvaraj, V., Sudan, R. J. J., Chinnappan, S., Bhuvan, A., & Santhakumar, K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1824812
“…and stabilization of hypoxia-inducible factor 1 alpha (HIF-1a) and activation of genes involved in the cell proliferation (Isaacs et al., 2005; Pollard et al., 2005) while the second model proposes that the insufficient fumarate synthesis at the site of DNA repair due to loss of FH leads to…”
BackgroundCevatemre, B. (2018) · Bursa Uludag University - AVESIS
Molecular genetic investigations of renal cell carcinoma predisposition
Smith, P. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.56770
Bruce‐Brand, C. (2020) · SUNScholar (Stellenbosch University)
Lineage-restricted Metabolic Identities of Mammary Epithelial Cells
Mahendralingam, M. J. (2019) · TSpace (University of Toronto)
Onyenekwu, C. P., Iczkowski, K. A., & Sheinin, Y. M. (2021) · Case Reports in Clinical Pathology · doi:10.5430/crcp.v8n1p5
Cao, Z. (2021) · Knowledge@UChicago (University of Chicago) · doi:10.6082/9bv2k-s2p30
Villarreal, B., & Nadilly, Y. (2021) · Figshare
Identification of an α-Ketoglutarate Analogue as an Anticancer Agent
Abla, H. (2021) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/9868
Mitochondrial metabolism and carcinogenesis
Aras, S., Purandare, N., & Grossman, L. I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00001-4
Silva, M. B. B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2021.tde-05082021-094821
Phäochromozytome [MAK Value Documentation in German language, 2010]
Arbeitsstoffe, D. F. S. S. Z. P. G., & Hartwig, A. (2012) · Wiley eBooks · doi:10.1002/3527600418.mbphaeod0049
Metadata
- Authors
- Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., Hargreaves, I. P., Heales, S. J., Chung, Y. L., Griffiths, J. R., Dalgleish, A., McGrath, J. A., Gleeson, M. J., Hodgson, S. V., Poulsom, R., Rustin, P., & Tomlinson, I. P. M.
- Affiliations
- St Thomas' Hospital (GB)
- Cancer Research UK (GB)
- Sheffield Children's Hospital (GB)
- University Hospital of Wales (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- St George's Hospital (GB)
- Guy's Hospital (GB)
- Inserm (FR)
- Corresponding author
- Pollard, P.J.
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-29
- Volume
- 14
- Issue
- 15
- Pages
- 2231-2239
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2136749294
- Cited by
- 865
- References
- 39
- Citations by year
- 2026: 28 · 2025: 26 · 2024: 15 · 2023: 29 · 2022: 37 · 2021: 48 · 2020: 37 · 2019: 56 · 2018: 48 · 2017: 34 · 2016: 47 · 2015: 58 · 2014: 52 · 2013: 55 · 2012: 48
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Human Molecular Genetics (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- fumarate hydratase, succinate dehydrogenase, Krebs cycle intermediates, fumarate accumulation, succinate accumulation, HIF-1α stabilization, hereditary leiomyomatosis and renal cell carcinoma, paraganglioma, pheochromocytoma, leiomyoma, microvessel density, vascular endothelial growth factor, reactive oxygen species
- MeSH terms
- Carcinoma, Renal Cell, Citric Acid Cycle, Female, Fumarate Hydratase, Humans, Leiomyoma, Neoplasms, Paraganglioma, Succinate Dehydrogenase, Tumor Cells, Cultured, Germ-Line Mutation, Vascular Endothelial Growth Factor A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.